An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes. [electronic resource]

By: Contributor(s): Producer: 20100709Description: 139-41 p. digitalISSN:
  • 1591-9528
Subject(s): Online resources: In: Clinical and experimental medicine vol. 10
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.